Centre Hospitalier Charles Perrens
Bordeaux, 33076, France
NCT Number: NCT05381883
The purpose of this study is identify the psychological impact of the coronavirus-19 pandemic on professionals in residential care facilities for old people and home help professionals in New-Aquitaine by :
1. Large-scale screening for the prevalence of mental health disorders among staff. 2. Identification of vulnerability and resilience factors. 3. Improving access to early care for affected professionals.
Trial opening soon.
Get Notified18 year–99 year
All sexes
Interventional
Not applicable
Bordeaux, 33076, France
This is a repeated cross-sectional descriptive study with two independent collection points six months apart, using socio-economic self-questionnaires and psychometric scales, which aims to measure the incidence of psychological disorders.
This study included the completion of questionnaires in a non-clinical population. This is a study aimed at describing a profile of psychological condition in adults.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will answer socio-demographic questions, questions about the lifetime experience of potentially traumatic events, the presence of a known psychological or medical disorder and the taking of medication, and a series of psychological assessment questionnaires.
The questionnaires, performed outside routine care, are as follows :
Posttraumatic stress disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders-5 Beck Depression Inventory-Fast Screen General Anxiety Disorder-7 Coping Inventory for Stressful Situations Maslach Burnout Inventory Medical Outcomes Study Short-Form
The total time for completing the questionnaires is estimated at 20 minutes
Time frame: Baseline
The appearance of symptoms of anxiety disorders measured through the General Anxiety Disorder-7 questionnaire A total score greater than 7 should lead to the hypothesis of a generalized anxiety disorder. A total score between 5 and 9 corresponds to mild anxiety, a score of 10 to 14 corresponds to moderate anxiety and a score above 15 corresponds to severe anxiety.
Time frame: Baseline
The appearance of symptoms of anxiety disorders measured through the Panic Disorder Self-Report questionnaire. This questionnaire is a 24-item self-report measure designed to diagnose panic disorder based on Diagnostic and Statistical Manual-IV and Diagnostic and Statistical Manual-V criteria.
Most of items are answered in a simple Yes/No fashion. Nevertheless, there are also some questions, for example about severity, which are answered on 5-point Likert scales. Not all of the questions have to be answered by every patient. If a panic disorder can already be excluded, the questionnaire stops.
Time frame: Baseline
Participants will answer the Posttraumatic stress disorder Checklist which is a questionnaire allowing the screening of post-traumatic stress disorder.
Min=0 max=80 Higher score mean a worse outcome
Time frame: Baseline
Participants will answer the Beck Depression Inventory- Fast Screen which is the questionnaire for screening for major depressive disorder Min = 0 Max =21 Higher score mean a worse outcome
Time frame: Baseline
Participants will answer the Coping Inventory for Stressful Situations which is the scale assesses the 4 types of coping strategies (emotion-focused, support-focused, problem-focused, avoidance-focused ).
There are three sub-scales :
Task oriented min=0 max=56 Emotional oriented min=0 max =42 Avoidance oreinted min =0 max =51
Time frame: Baseline
Participants will answer the Maslach Burnout Inventory which is the questionnaire allowing the screening of a burn-out.
There are three sub-scales :
Burnout score min =0 max =54 Depersonalization score / Loss of empathy min =0 max=30 For these two subscales: Higher scores mean a worse outcome Personal Achievement Score min = 0 max=48 For this subscale: Higher score mean a better outcome
Time frame: Baseline
Participants will answer the Medical Outcomes Study Short-Form which is the questionnaire to assess the quality of life Min=0 max=100 Higher score mean a better outcome
Time frame: Baseline
The consumption of psychoactive substances will be assessed through a multiple-choice menu, allowing to tick the substances consumed by the participant during the last month. The categories of psychoactive substances are: anxiolytics and sedatives (eg benzodiazepines, hypnotics etc), psycho-stimulants (eg cocaine, amphetamines, ecstasy etc), opiates and related drugs (eg codeine, heroin etc), cannabis, alcohol and tobacco. According to the items, the person will indicate for each psychoactive substance checked the level of consumption (absent, new, increasing, constant).
Contact information is provided by the study sponsor or research team.
Charles-Henry MARTIN, MD
CONTACT
Helen SAVARIEAU
CONTACT
Centre Hospitalier Charles Perrens, Bordeaux
Other Gov
Acronym: SILVER NA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06231225
COVID-19, COVID-19 Pandemic
View Trial DetailsNCT05096260
COVID-19, COVID-19 Pandemic
Ann Arbor, Michigan, United States
View Trial DetailsNCT05188651
COVID-19, COVID-19 Pandemic
Roma, RM, Italy
View Trial DetailsNCT07436572
COVID-19, COVID-19 Pandemic
Gaziantep, Turkey (Türkiye)
View Trial Details